Qiagen N.V. (QGEN)

NYQ – Real vaqt narxi. Valyuta: USD

33.70

+1.07 (3.28%)

Yopilishda: May 12, 2026, 4:00 PM EDT

09.05.2026

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

07.05.2026

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from "at least 5% CER" to just 1-2% CER and cut adjusted diluted EPS guidance to at least $2.43 from a prior floor of $2.50 CER. Shareholders who lost money on QGEN are encouraged to submit their information to discuss their legal rights.

07.05.2026

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a separate AI-enabled risk stratification tool for TB progression, building on growing adoption of Diasorin LIAISON detection systems and a new automation partnership with Inpeco. These developments are intended to help higher-throughput labs scale testing as screening.

07.05.2026

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.58 per share a year ago.

07.05.2026

Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

06.05.2026

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

New York, New York--(Newsfile Corp. - May 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.

06.05.2026

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Qiagen N.V. (“Qiagen” or “the Company”) (NYSE: QGEN) for violations of the securities laws.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Qiagen N.V. (QGEN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

Videolar

No Data

Press-relizlar

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

Videolar

No Data

Press-relizlar

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

Search stocks

Qiagen N.V. (QGEN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

Videolar

No Data

Press-relizlar

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates

Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

Videolar

No Data

Press-relizlar

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm